Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SFNC
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.25 0.15 0.15
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -49.03 -100.58 197.33
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.24 27.44 27.37
Cash -3.71 28.97 30.09
Capex -50.62 -0.08 -0.05
Free Cash Flow -88.29 0.39 3.31
Revenue 5.81 2.92 2.76
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -11.62 0.88 1.00
Operating Margin 21.48 0.14 0.12
ROA 61.71 < 0.005 < 0.005
ROE 62.00 0.01 < 0.005
ROIC -8.04 < 0.005 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SFNC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SFNC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SFNC is permitted for members.